Le Lexique

Peptide Glossary

Every term a research buyer runs into, written the way it would be explained at the bench — mechanism first, jargon second. Grouped by how the term is used rather than alphabetically, so the entries around each one are the ones you actually need next.

Mechanisms

Peptide: A short chain of amino acids linked by peptide bonds.; A peptide is a chain of amino acids — typically fewer than about fifty — joined end to end. Where proteins are large and structurally folded, peptides are small and comparatively simple, which is why they are widely used as reference standards in laboratory work: they can be synthesized to a defined sequence, purified, and characterized with high confidence. In signaling research, peptides are studied because many of the body's own messengers are peptides, so synthetic analogs are useful tools for probing how a given receptor or pathway behaves in vitro.; See also: Analog · Lyophilization · Sequence
Analog: A synthetic variant of a natural peptide with deliberate sequence changes.; An analog is a modified version of a naturally occurring peptide. Researchers substitute, delete, or chemically protect specific residues to change how the molecule behaves — most often to slow enzymatic degradation, adjust receptor selectivity, or extend plasma half-life in a model system. Comparing an analog against its parent sequence is one of the cleanest ways to isolate which part of a molecule drives which part of a signaling response.; See also: Half-life · Receptor agonist
Receptor agonist: A molecule that binds a receptor and activates its downstream signal.; Receptors are proteins that sit on or inside a cell and wait for a specific molecular key. An agonist is a key that both fits the lock and turns it — binding the receptor and triggering the intracellular cascade that follows. An antagonist fits but does not turn, blocking the natural ligand. Much of preclinical peptide research is the study of how strongly (potency) and how completely (efficacy) a candidate agonist activates a given receptor.; See also: GLP-1 · GIP · Melanocortin receptor
Signaling cascade: The chain of intracellular events triggered after a receptor is activated.; Receptor activation rarely does anything by itself. It sets off a relay — second messengers such as cyclic AMP or calcium, kinases that phosphorylate their targets, and finally transcription factors that change which genes a cell reads. Because each step amplifies the last, a very small amount of peptide can produce a large measured change in a cell culture. Laboratory endpoints usually measure a step in this cascade rather than the binding event itself.; See also: cAMP · Kinase
Angiogenesis: The formation of new blood vessels from existing vasculature.; Angiogenesis is the process by which endothelial cells sprout, migrate, and organize into new capillaries. In vitro it is commonly assessed with tube-formation and migration assays; in animal models it is measured histologically. Several tissue-repair reference peptides are studied specifically for how they modulate angiogenic markers such as VEGF expression, because vascular supply is rate-limiting for repair in most tissues.; See also: VEGF · Fibroblast
Collagen synthesis: Production of the structural protein that gives tissue its tensile strength.; Collagen is the scaffold protein of skin, tendon, and ligament. Fibroblasts assemble procollagen, secrete it, and cross-link it into fibrils. Research endpoints include hydroxyproline content, type I/III collagen ratios, and gene-expression panels. Copper-binding and matrix-signaling peptides are studied for how they shift these markers in dermal fibroblast culture.; See also: Fibroblast · Extracellular matrix
Mitochondrial biogenesis: The cellular process of producing new mitochondria.; Mitochondria are the cell's energy plants, and their number and quality are actively regulated. Biogenesis is coordinated largely through the AMPK–PGC-1α axis: when cellular energy is scarce, AMPK activates and PGC-1α drives transcription of mitochondrial genes. Mitochondrial-derived peptides and NAD-pathway compounds are studied in this context using oxygen-consumption rate, mtDNA copy number, and respiratory-complex assays.; See also: AMPK · NAD+ · Sirtuin
Neurotrophic signaling: Pathways that support neuron survival, growth, and synaptic plasticity.; Neurotrophins such as BDNF and NGF bind Trk-family receptors and promote neurite outgrowth, synapse formation, and cell survival. Neuropeptide research in this area typically measures BDNF/NGF expression, neurite length in cultured neurons, or electrophysiological markers of plasticity. It is a mechanism-level field: the endpoints are molecular, not behavioral claims.; See also: BDNF · Synaptic plasticity

Receptors & Pathways

GLP-1: Glucagon-like peptide-1 — an incretin hormone receptor pathway.; GLP-1 is released from intestinal L-cells after nutrient intake and acts on a G-protein-coupled receptor to raise intracellular cAMP. In preclinical models the pathway is studied for glucose-dependent insulin secretion, gastric-emptying rate, and central satiety signaling. Because native GLP-1 is degraded within minutes by DPP-4, most research analogs are engineered for resistance to that enzyme.; See also: GIP · Incretin · DPP-4
GIP: Glucose-dependent insulinotropic polypeptide — the second incretin axis.; GIP is the other major incretin, released from duodenal K-cells. Its receptor is expressed in pancreatic beta cells, adipose tissue, and regions of the central nervous system. Dual and triple receptor agonists are studied for how combined GIP and GLP-1 activation changes measured signaling relative to either pathway alone — a central question in current metabolic-pathway literature.; See also: GLP-1 · Incretin
GHRH axis: Growth-hormone-releasing hormone signaling at the pituitary.; GHRH is a hypothalamic peptide that binds pituitary somatotrophs and stimulates pulsatile growth-hormone release, which in turn drives hepatic IGF-1 expression. GHRH analogs are studied for how sequence modifications change pulse amplitude and duration in model systems. Ghrelin-receptor agonists act on a parallel input to the same cells, which is why the two families are frequently examined together in comparative work.; See also: IGF-1 · Ghrelin receptor
Ghrelin receptor: GHS-R1a — the growth-hormone secretagogue receptor.; The ghrelin receptor is a G-protein-coupled receptor expressed in the pituitary and hypothalamus. Selective synthetic agonists are used in research to probe growth-hormone release independent of GHRH input, and to separate secretagogue effects from appetite-related signaling in controlled models.; See also: GHRH axis
Melanocortin receptor: A receptor family (MC1R–MC5R) involved in pigmentation and CNS signaling.; The melanocortin family spans five receptor subtypes with distinct tissue distributions — MC1R in melanocytes, MC3R and MC4R in the central nervous system, MC5R in exocrine tissue. Synthetic melanocortin analogs are studied for subtype selectivity and for the downstream cAMP responses each subtype produces.; See also: cAMP
AMPK: AMP-activated protein kinase — the cell's energy sensor.; AMPK activates when the ratio of AMP to ATP rises, signaling low cellular energy. Once active it switches on catabolic pathways such as glucose uptake and fatty-acid oxidation while switching off anabolic ones. It is one of the most frequently measured endpoints in metabolic peptide research because phosphorylated AMPK is a clean, quantifiable readout.; See also: Mitochondrial biogenesis · Sirtuin
Sirtuin: A family of NAD-dependent deacetylase enzymes.; Sirtuins (SIRT1–SIRT7) remove acetyl groups from proteins including histones, and they require NAD+ as a cofactor — which links their activity directly to cellular energy status. They are studied in the context of mitochondrial function, DNA-repair signaling, and stress response.; See also: NAD+ · AMPK
NAD+: Nicotinamide adenine dinucleotide — a central metabolic coenzyme.; NAD+ shuttles electrons in redox reactions and is consumed as a substrate by sirtuins and PARP enzymes. Because cellular NAD+ concentration declines in many aging models, restoring or measuring it is a recurring question in longevity research. Endpoints include NAD+/NADH ratio, sirtuin activity, and mitochondrial respiration.; See also: Sirtuin · Mitochondrial biogenesis

Laboratory Practice

Lyophilization: Freeze-drying, the standard way peptides are stabilized for storage.; Lyophilization freezes an aqueous peptide solution and then removes the water by sublimation under vacuum. The result is a dry cake or powder that is far more stable than solution, because hydrolysis and oxidation both require water and mobility. Lyophilized reference peptides are stored sealed and cold, and are reconstituted only immediately before analysis.; See also: Reconstitution · Bacteriostatic water
Reconstitution: Returning a lyophilized peptide to solution with a suitable diluent.; Reconstitution is performed by adding diluent slowly down the inner wall of the vial rather than directly onto the cake, then allowing the material to dissolve without agitation. Shaking introduces shear and foaming, both of which can denature peptide structure. Concentration is calculated as total mass in the vial divided by diluent volume added.; See also: Bacteriostatic water · Lyophilization
Bacteriostatic water: Sterile water containing 0.9% benzyl alcohol as a preservative.; Bacteriostatic water is the standard laboratory diluent for multi-draw reference vials. The benzyl alcohol inhibits bacterial growth, which allows a reconstituted vial to be sampled more than once over a working interval. It is supplied separately from reference compounds and is not included with them.; See also: Reconstitution
Cold chain: Maintaining controlled low temperature from packing to storage.; Peptide integrity is temperature-dependent. Lyophilized material tolerates ambient transit for short periods, but long-term stability requires refrigeration or freezing. Reconstituted solution should be kept refrigerated and protected from light. Repeated freeze–thaw cycles are avoided because each cycle concentrates solutes and stresses molecular structure.; See also: Lyophilization
Half-life: The time for half of a compound to be cleared or degraded in a system.; Half-life describes how quickly a molecule disappears from a model system through enzymatic degradation, renal clearance, or receptor-mediated uptake. It is a property of the molecule and the system together, not the molecule alone. Structural strategies for extending it include DPP-4-resistant substitutions, fatty-acid acylation, and drug-affinity-complex conjugation.; See also: Analog · DPP-4

Analytics & Quality

HPLC: High-performance liquid chromatography — the standard purity assay.; In reverse-phase HPLC, a sample is pushed through a hydrophobic column and its components separate by how strongly they interact with the stationary phase. The detector plots absorbance against elution time; the target peptide appears as a dominant peak, and purity is reported as that peak's area divided by total peak area. A ≥98% result means impurities account for under two percent of detected material.; See also: Mass spectrometry · Certificate of Analysis
Mass spectrometry: Identity confirmation by measuring exact molecular mass.; HPLC tells you how pure a sample is; mass spectrometry tells you what it is. The instrument ionizes the sample and measures mass-to-charge ratio, which is compared against the theoretical mass calculated from the intended amino-acid sequence. A match within tolerance confirms identity; a systematic offset can reveal a missing residue or an unintended modification.; See also: HPLC · Sequence
Certificate of Analysis: The batch-specific document reporting assay results.; A Certificate of Analysis (COA) records the tests run on a specific production batch — typically HPLC purity, mass-spec identity confirmation, appearance, and where applicable heavy-metal and endotoxin screening. A COA is only meaningful when it is batch-specific and issued by an independent laboratory; a generic certificate that is not tied to a lot number carries no analytical weight.; See also: HPLC · Mass spectrometry
Quantitative assay: Measurement of how much active compound a vial actually contains.; A purity assay answers 'what fraction of what is here is the target molecule.' A quantitative assay answers a different question: 'how many milligrams of target are in this vial.' Both matter. A vial can be highly pure and still under-filled, which is why quantitative content testing is reported alongside purity.; See also: Certificate of Analysis · HPLC
Heavy-metal screening: Elemental testing for trace metallic contamination.; Heavy-metal screening — usually by ICP-MS — checks for trace lead, arsenic, cadmium, and mercury that can be introduced by reagents, catalysts, or equipment during synthesis. Results are reported in parts per million or billion against defined limits.; See also: Certificate of Analysis
Sequence: The ordered list of amino acids that defines a peptide.; A peptide's sequence, written from the N-terminus to the C-terminus in single- or three-letter amino-acid code, is its complete identity. Everything else — mass, charge, solubility, receptor affinity — follows from it. Two vials with the same name but different sequences are different compounds, which is why sequence and molecular formula are published alongside purity data.; See also: Mass spectrometry · Peptide
Endotoxin: Bacterial cell-wall fragments that can confound cell-culture results.; Endotoxins are lipopolysaccharides shed by Gram-negative bacteria. Even at very low concentrations they provoke inflammatory signaling in cultured cells, which can produce results an experimenter mistakenly attributes to the test compound. Endotoxin testing (LAL assay) is therefore part of quality screening for materials intended for cell work.; See also: Certificate of Analysis

Guides

Long-form laboratory reference guides.

Research Library

Compound-by-compound profiles and citations.

Compare

Put compounds side by side.